These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17529996)

  • 21. Hematopoietic SCT in patients with a history of invasive fungal infection.
    Zhang P; Song A; Wang Z; Feng S; Qiu L; Han M
    Bone Marrow Transplant; 2009 Apr; 43(7):533-7. PubMed ID: 19104496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT.
    El-Cheikh J; Venton G; Crocchiolo R; Fürst S; Faucher C; Granata A; Oudin C; Coso D; Bouabdallah R; Vey N; Duran S; Fougereau E; Berger P; Chabannon C; Blaise D
    Bone Marrow Transplant; 2013 Nov; 48(11):1472-7. PubMed ID: 23749104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemopoietic progenitor cell transplantation in patients with previous history of invasive fungal infection.
    Vaidya SJ; Ortín M; López-Duarte M; Sirohi B; Powles R; Treleaven J; Richard C
    Leuk Lymphoma; 2005 Aug; 46(8):1143-50. PubMed ID: 16085554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comedication of caspofungin acetate and cyclosporine A after allogeneic haematopoietic stem cell transplantation leads to negligible hepatotoxicity.
    Christopeit M; Eikam M; Behre G
    Mycoses; 2008; 51 Suppl 1():19-24. PubMed ID: 18471157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Caspofungin in Unclassified Invasive Fungal Infection Cases: A Retrospective Analysis of Patients with Hematological Malignancies in China.
    Zhang X; Hu J; Hu Y; Huang H; Jin J; Li J; Liu Q; Shao Z; Wang J; Wang Q; Wu D; Huang X
    Med Sci Monit; 2018 Jul; 24():5258-5270. PubMed ID: 30056458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The clinical characteristic and risk factors for the incidence of invasive fungal infection in patients following allogeneic hematopoietic stem cell transplantation].
    Zhang Y; Liu C; Liu QF; Sun J; Fan ZP; Xu D; Jiang QL
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2814-7. PubMed ID: 20137659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
    Cherif H; Kalin M; Björkholm M
    Eur J Haematol; 2006 Oct; 77(4):288-92. PubMed ID: 16856930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients.
    Chan TS; Gill H; Hwang YY; Sim J; Tse AC; Loong F; Khong PL; Tse E; Leung AY; Chim CS; Lie AK; Kwong YL
    Ann Hematol; 2014 Mar; 93(3):493-8. PubMed ID: 23949318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
    Gahn B; Schub N; Repp R; Gramatzki M
    Eur J Med Res; 2007 Aug; 12(8):337-40. PubMed ID: 17933709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
    Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
    Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
    Aliff TB; Maslak PG; Jurcic JG; Heaney ML; Cathcart KN; Sepkowitz KA; Weiss MA
    Cancer; 2003 Feb; 97(4):1025-32. PubMed ID: 12569602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed ABLC prophylaxis after allogeneic stem-cell transplantation.
    Jansen J; Akard LP; Wack MF; Thompson JM; Dugan MJ; Leslie JK; Mattison R
    Mycoses; 2006 Sep; 49(5):397-404. PubMed ID: 16922792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergency and elective pulmonary surgical resection in haematological patients with invasive fungal infections: a report of 50 cases in a single centre.
    Chretien ML; Legouge C; Pagès PB; Lafon I; Ferrant E; Plocque A; Favennec C; Estivalet L; Bottolier-Lemallaz E; Dalle F; Bastie JN; Bernard A; Caillot D
    Clin Microbiol Infect; 2016 Sep; 22(9):782-787. PubMed ID: 26806254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.
    Vehreschild MJ; von Bergwelt-Baildon M; Tran L; Shimabukuro-Vornhagen A; Wisplinghoff H; Bangard C; Cornely OA; Vehreschild JJ
    Eur J Haematol; 2014 Nov; 93(5):400-6. PubMed ID: 24798021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder.
    Castagnola E; Moresco L; Cappelli B; Cuzzubbo D; Moroni C; Lanino E; Faraci M
    J Chemother; 2007 Jun; 19(3):339-42. PubMed ID: 17594932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Use of Voriconazole as Primary Prophylaxis for Invasive Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation: A Single Center's Experience.
    Atoui A; Omeirat N; Fakhreddine O; El Alam R; Kanafani Z; Abou Dalle I; Bazarbachi A; El-Cheikh J; Kanj SS
    J Fungi (Basel); 2021 Oct; 7(11):. PubMed ID: 34829213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation.
    Groetzner J; Kaczmarek I; Wittwer T; Strauch J; Meiser B; Wahlers T; Daebritz S; Reichart B
    J Heart Lung Transplant; 2008 Jan; 27(1):1-6. PubMed ID: 18187079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients.
    Glasmacher A; Cornely OA; Orlopp K; Reuter S; Blaschke S; Eichel M; Silling G; Simons B; Egerer G; Siemann M; Florek M; Schnitzler R; Ebeling P; Ritter J; Reinel H; Schütt P; Fischer H; Hahn C; Just-Nuebling G
    J Antimicrob Chemother; 2006 Jan; 57(1):127-34. PubMed ID: 16308418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal agents for secondary prophylaxis based on response to initial antifungal therapy in allogeneic hematopoietic stem cell transplant recipients with prior pulmonary aspergillosis.
    Liu Q; Lin R; Sun J; Xiao Y; Nie D; Zhang Y; Huang F; Fan Z; Zhou H; Jiang Q; Zhang F; Zhai X; Xu D; Wei Y; Song J; Li Y; Feng R
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1198-203. PubMed ID: 24769013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation.
    Kriván G; Sinkó J; Nagy IZ; Goda V; Reményi P; Bátai A; Lueff S; Kapás B; Réti M; Tremmel A; Masszi T
    Acta Biomed; 2006; 77 Suppl 2():17-21. PubMed ID: 16918062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.